{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

GeoVax Addresses Identification of New Mpox Variant

December 11, 2025Continued Mpox Evolution Underscores Dependence on a Single Global Supplier, Reinforcing the Critical Importance of GeoVax’s Accelerated GEO-MVA Program ATLANTA, GA - December 11, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today addressed reports from UK health authorities confirming the emergence of a newly evolved “recombinant” Mpox strain.


Cuffless Blood Pressure Technologies In Wearable Devices Show Promise To Transform Care

December 11, 2025Statement Highlights: Over the past decade, the number and type of cuffless devices to measure blood pressure, such as smartwatches, rings, patches and fingertip monitors, have increased significantly. However, many personal wearable devices have not been proven to be accurate or reliable for real world use, such as during exercise, sleep or daily activity or after taking medication that affects blood pressure.


Florian Schuhbauer Appointed to the Supervisory Board of PNE AG

December 10, 2025CUXHAVEN, Germany - December 10, 2025 (NEWMEDIAWIRE) - Florian Schuhbauer, co-founder and Co-Chief Investment Officer of Active Ownership Capital, has been appointed by the District Court of Tostedt as a member of the Supervisory Board of PNE AG until the next Annual General Meeting. He succeeds Marc van’t Noordende, who stepped down from the Supervisory Board with effect from 29 July 2025.


The Platform Group AG Successfully Completes Planned Portfolio Disposal

December 10, 2025DUSSELDORF - December 10, 2025 (NEWMEDIAWIRE) - The Platform Group AG (ISIN DE000A2QEFA1, “TPG”), a leading software company for platform solutions, has completed the disposal of three portfolio companies. As announced by the Management Board in its presentation on 12 November 2025, three portfolio companies classified as non-core assets were disposed of as planned in the fourth quarter of 2025.


Cherry SE: Rogier Volmer to Join Cherry SE as Interim CEO; CEO Oliver Kaltner to Transition to Advisory Role at Conclusion of Contract on December 31, 2025

December 10, 2025 Rogier Volmer appointed as Interim CEO by the Supervisory Board of Cherry SE with effect from January 1, 2026 Oliver Kaltner leaves the Management Board at his own request upon the expiration of his current term on December 31, 2025, and will continue to provide advisory support for the Company’s M&A efforts MUNICH - December 10, 2025 (NEWMEDIAWIRE) - Cherry SE [ISIN: DE000A3CRRN9] announced today that Rogier Volmer has unanimously been appointed by the Supervisory Board as Interim Chief Executive Officer and Management Board member with effect from January 1, 2026. Oliver Kaltner is leaving the Management Board at his own request upon the expiration of his current term on December 31, 2025.


Museum to Celebrate Sabra, First Israeli Superhero

December 10, 2025 GLENDALE, CA - December 10, 2025 (NEWMEDIAWIRE) - The Martial Arts History Museum will host Sabra Day, a first-of-its-kind celebration honoring Sabra (Ruth Bat-Seraph), Marvel Comics’ groundbreaking Israeli superheroine. Beginning at 5:30 PM PST, the event will bring together fans, scholars, cultural leaders, and members of the Jewish and Israeli communities for a night celebrating heroism, identity, and Sabra’s unique place in pop culture.


HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal

December 10, 2025LOS ANGELES, CA - December 10, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for arrhythmia assessment after successfully appealing a prior NSE determination. The patented cable-free technology captures cardiac electrical signals in three non-coplanar dimensions to generate a synthesized 12-lead ECG that can be reviewed remotely by a board-certified cardiologist, enabling patients to capture meaningful ECG data wherever symptoms occur.


Angkor Resources Identifies Gold Prospect on Andong Meas License, Cambodia

December 10, 2025GRANDE PRAIRIE, ALBERTA - December 10, 2025 (NEWMEDIAWIRE) - ANGKOR RESOURCES CORP. (TSXV: ANK) (“ANGKOR” OR “THE COMPANY”) announces an additional gold target, named CZ Gold, on the west side of the Canada Wall prospect on the Andong Meas exploration license in Ratanakiri Province, Cambodia.


Aristocrat Group Corporation Launches Gulf Of Merica™ Agave Spirit, Strengthening Revenue Strategy and Expanding Presence in High-Growth Category

December 10, 2025HOUSTON, TEXAS - December 10, 2025 (NEWMEDIAWIRE) - Aristocrat Group Corporation (OTC: ASCC) today announced the launch of Gulf Of Merica™ Agave Spirit, a significant expansion of the company’s brand portfolio that positions ASCC to participate in one of the fastest-growing, highest-margin segments of the global spirits industry. The introduction of Gulf Of Merica™ marks a strategic advancement for ASCC as it shifts toward diversified, scalable revenue channels with strong consumer demand.


GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board

December 10, 2025Newly Appointed Members Include Leaders in Vaccine Immunology, T-Cell Science, and Clinical Research ATLANTA, GA - December 10, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancers, today announced an update to its Scientific Advisory Board (SAB), welcoming internationally recognized experts whose work spans vaccine design, T-cell immunology, viral pathogenesis, and immunocompromised-host medicine.


Decile Launches Luma AI, the First AI Analyst Built for Ecommerce

December 10, 2025Luma AI by Decile Helps Ecommerce Brands Move Faster and Think Smarter - Transforming Complex Data Into Clear, Actionable Insights ARLINGTON, VA - December 10, 2025 (NEWMEDIAWIRE) - Decile, an advanced analytics platform that democratizes access to insights, today announced the launch of Luma, a conversational AI analyst that allows ecommerce brands to understand performance, uncover opportunities, and act faster than ever. Luma behaves like your best analyst by combining ecommerce expertise with a trusted data foundation to interpret results, identify causes, and recommend next steps.


Uterine Fibroids Linked to Elevated Heart Disease Risk

December 10, 2025Research Highlights: Long-term heart disease risk among women diagnosed with uterine fibroids was more than 80% higher than in women without uterine fibroids, according to a 10-year study of more than 2. 7 million U.


Vonovia Supervisory Board Appoints Katja Wunschel as Chief Development Officer and Renews Ruth Werhahn's Contract Ahead of Schedule

December 9, 2025 Supervisory Board unanimously decides to appoint Katja Wunschel as new CDO from June 1, 2026 Contract of CHRO Ruth Werhahn renewed ahead of schedule until September 30, 2029 BOCHUM, Germany - December 9, 2025 (NEWMEDIAWIRE) - The Supervisory Board of Vonovia SE (“Vonovia”) unanimously decided to appoint Katja Wunschel as new Chief Development Officer (CDO) of Vonovia. She will join the company on April 1, 2026, and will take up her position on the Executive Board on June 1, 2026.


GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin® Gene Therapy

December 9, 2025Patent Protects Novel Application of Gedeptin Therapy Across Multiple Solid Tumor Types; Supports Expansion of Gedeptin Product Platform ATLANTA, GA - December 9, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies against cancers and infectious diseases, today announced the issuance of U.